Font Size:
Celliance and Novo Nordisk Extend Insulin Distribution Alliance
Business Review Editor
Abstract
Celliance entered into a distribution deal with Novo Nordisk. Under the terms of the deal Novo Nordisk extends the supply of recombinant human insulin to Celliance for a further 4 years.
Full Text: pdf
Add comment
This work is licensed under a Creative Commons Attribution 3.0 License.